Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1125506

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV.
	tabling member printed	Baroness Masham of Ilton
	uin	HL15601
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Public Health England, in partnership with NHS England and the Department, is taking steps to improve vaccination coverage in England, including for people living with HIV.</p><p>These steps include initiatives to improve access to the immunisation programme; communication with the public; data to identify underserved individuals and populations; and training for healthcare professionals, changes to vaccination eligibility criteria; launching disease elimination strategies; running targeted social media campaigns; providing information leaflets in multiple languages and running e-learning programme for healthcare practitioners.</p><p>Certain vaccines are delivered through sexual health services that particularly benefit people living with HIV. This includes vaccines for hepatitis A, hepatitis B and human papillomavirus. People living with HIV are in the influenza risk groups and are invited for the flu vaccine on an annual basis.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:50:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1850 label Biography information for Baroness Masham of Ilton

890446

	registered interest
	date	24/04/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for a new HIV vaccine to be available on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	137557
	answer	answer is ministerial correction date of answer 01/05/2018 answer text <p>There is currently no licensed vaccine against HIV or acquired immune deficiency syndrome. It is therefore not possible to determine any timetable for a new HIV vaccine to be available on the National Health Service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/05/2018 11:41:12 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

389888

	registered interest
	date	14/07/2015
	answering body	Department for International Development
	answering dept id	20
	answering dept short name	International Development
	answering dept sort name	International Development
	hansard heading	HIV Infection: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for International Development, if she will reassess her Department's decision to reduce funding for the development of an AIDS vaccine.
	tabling member constituency	Finchley and Golders Green
	tabling member printed	Mike Freer
	uin	7073
	answer	answer is ministerial correction date of answer 21/07/2015 answer text <p>DFID is strongly committed to tackling HIV through the appropriate vehicles but has no plans to reassess funding levels for the development of an AIDS vaccine. In the last 2-3 years there have been some promising and significant scientific advances, but an effective vaccine is still many years away and the science has now moved back to the laboratory. DFID’s comparative advantage does not lie in supporting basic science. The recent award to the International AIDS Vaccine Initiative recognises that other agencies, supporting basic scientific research, are better placed to provide support in this area.</p> answering member constituency Welwyn Hatfield answering member printed Grant Shapps question first answered 21/07/2015 16:35:28 answering member 1582 label Biography information for Grant Shapps
	tabling member	4004 label Biography information for Mike Freer

167395

	registered interest
	date	02/12/2014
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	HIV Infection: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Innovation and Skills, what support his Department provides to research into finding a vaccine for HIV; and if he will make a statement.
	tabling member constituency	Brighton, Kemptown
	tabling member printed	Simon Kirby
	uin	216742
	answer	answer is ministerial correction date of answer 09/12/2014 answer text <p>The Department for Business, Innovation and Skills (BIS) supports research into HIV/AIDS through the UK Research Councils who support a broad portfolio of research addressing different aspects of the disease. This includes research on vaccines and interventions.</p><p> </p><p> </p><p> </p><p>Research supported by the Research Councils includes Medical Research Council (MRC) funded studies which aim to understand the mechanisms of HIV infection through to novel strategies for preventing and controlling infections through research on human behaviour and lifestyle. Research supported by the Economic and Social Research Council (ESRC) includes an evaluation of the impact of health care schemes in Rwanda providing basic preventive and curative health care services and HIV/AIDS treatment in addition to Engineering and Physical Sciences Research Council (EPSRC) funded research on drug delivery and vaccine delivery technology involving nanomedicines.</p><p> </p><p> </p><p> </p><p>Researchers are also using the Diamond Light Source to advance the understanding of how HIV and other retroviruses infect human cells and replicate to inform the development of better treatments. The Diamond Light Source is the UK’s national synchrotron, funded by the Science and Technology Facilities Council (STFC).</p><p> </p><p> </p><p> </p><p>The UK is also a member of the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis, malaria and other neglected diseases. In December 2014 the second phase of the partnership, EDCTP2 was launched aiming to contribute over 1billion euros over the next 10 years. Further information can be found at: <a href="http://www.edctp.org/" target="_blank">http://www.edctp.org/</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 216743 question first answered 09/12/2014 13:12:54 answering member 4020 label Biography information for George Freeman
	tabling member	3929 label Biography information for Simon Kirby